Floatz logo

Tranexamic Acid

Liver Cancer

Konkuk University Medical CenterSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

109 Active assets in the Liver Cancer cohort.

Asset / SponsorPhaseRating
Dexmedetomidine
Uppsala University Hospital
Phase 4BBB
Adriamycin
Shanghai Zhongshan Hospital
Phase 4BB
Xaliplatin
Sun Yat-sen University
Phase 3BB
Sufentanyl
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB
Jnj-54135419
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB

View all 50 →

Same molecule, other indications

Tranexamic Acid is also rated in:

intracerebral hemorrhageActive
BB
Indicative · Phase 4
71 / 100
View asset →
post-operative wound seroma, non-human animalDormant
BB
Indicative · Phase 4
69 / 100
View asset →
brain injuryDormant
BB
Indicative · Phase 3
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →